EUVIMEDEUVIMED entdecken
Open Access

Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer

Emmanuel Naveen Raj, Chia-Jung Li, Shih-Hsuan Cheng, Su-Boon Yong, Zhi-Hong Wen, An-Jen Chiang

Oncology Research · 2026 · 1-10

DOI: 10.32604/or.2026.079551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Emmanuel Naveen Raj und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Ubiquitin-Conjugating Enzymes, Biomarkers, Tumor, Topotecan. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsUbiquitin-Conjugating EnzymesBiomarkers, TumorTopotecanHumansFemalePrognosisTumor MicroenvironmentMultiomicsGene Expression Regulation, NeoplasticSpatial TranscriptomicsGene Expression Profiling

Stichwörter der Autor:innen

UBE2Ccervical cancerimmune infiltrationpharmacogenomicsscRNA-seqspatial transcriptomicstumor-associated macrophages

Substanzen

Ubiquitin-Conjugating EnzymesUBE2C protein, humanBiomarkers, TumorTopotecan

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
  • Institute of BioPharmaceutical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.
  • National Museum of Marine Biology & Aquarium, Pingtung, Taiwan.
  • Center of General Education, Cheng Shiu University, Kaohsiung, Taiwan.
  • Center of General Education, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan.
  • Department of Allergy and Immunology, China Medical University Children's Hospital, Taichung, Taiwan.

Zitieren

APA

Raj, E. N., Li, C. J., Cheng, S. H., Yong, S. B., Wen, Z. H., & Chiang, A. J. (2026). Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.079551

Vancouver

Raj EN, Li CJ, Cheng SH, Yong SB, Wen ZH, Chiang AJ. Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.079551

BibTeX
@article{Raj2026,
  author = {Raj, Emmanuel Naveen and Li, Chia-Jung and Cheng, Shih-Hsuan and Yong, Su-Boon and Wen, Zhi-Hong and Chiang, An-Jen},
  title = {Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer},
  journal = {Oncology Research},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {1--10},
  doi = {10.32604/or.2026.079551}
}
Kostenlos starten →